[Skip to Content]
[Skip to Content Landing]
Views 1,939
Citations 0
From The JAMA Network
June 27, 2017

High-Intensity StatinsGuideline Expectations and Clinical Application

Author Affiliations
  • 1Division of Cardiology, Department of Internal Medicine, University of Texas McGovern Medical School, Houston
JAMA. 2017;317(24):2543-2544. doi:10.1001/jama.2017.5781

There have been major advances in the understanding and management of atherosclerotic cardiovascular disease (ASCVD). Central to these was the discovery of the role of cholesterol-containing lipoprotein particles in the atherosclerotic process and the development of lipid-lowering agents, particularly statins. Despite substantial and consistent evidence to support a causal link between statin use and prevention of ASCVD events, there is still debate regarding the appropriate administration of statins, particularly with regard to primary prevention.

First Page Preview View Large
First page PDF preview
First page PDF preview
×